Header cover image
  • Investing Ideas
  • /
  • Swiss Pharmaceuticals & Biotech High Return On Equity, Low Debt

Swiss Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Novartis

Market Cap: CHF 192.1b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 98.07

7D

1.4%

1Y

4.0%